Immunoadsorption and its application for desensitizing incompatible kidney transplant candidates who have a potential living donor

Sébastien MAGGIONI, Eric FAUBEL, Martine HERMELIN, Asma ALLAL, Lionel ROSTAING

Анотація


Plasmapheresis is widely used to remove potential deleterious antibodies from the blood. Because the volume of treated plasma is limited, plasmapheresis can be replaced by immunoadsorption (IA), a more tedious but sophisticated technique that enables treatment of larger volumes of plasma, i.e., > 4 L vs. 1.5–2 L. We have implemented in our department IA technique to replace plasmapheresis when we launched our ABO-incompatible (ABOi) and HLA-incompatible (HLAi) kidney-transplant programs with living kidney donors. In this setting, isoagglutinin titers (ABOi) or donor-specific alloantibodies (HLAi) have to be decreased drastically at pretransplant by apheresis and immunosuppression.


Повний текст:

PDF (Русский)

Посилання

  • Поки немає зовнішніх посилань.